HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-PD-1 and Anti-PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes.

AuthorsMahnaz Mellati, Keith D Eaton, Barbara M Brooks-Worrell, William A Hagopian, Renato Martins, Jerry P Palmer, Irl B Hirsch
JournalDiabetes care (Diabetes Care) Vol. 38 Issue 9 Pg. e137-8 (Sep 2015) ISSN: 1935-5548 [Electronic] United States
PMID26116720 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • B7-H1 Antigen
  • CD274 protein, human
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
Topics
  • Adenocarcinoma (drug therapy, immunology)
  • Adenocarcinoma of Lung
  • Aged
  • Antibodies, Monoclonal (adverse effects, therapeutic use)
  • B7-H1 Antigen (immunology)
  • Carcinoma, Squamous Cell (drug therapy, immunology)
  • Diabetes Mellitus, Type 1 (etiology, immunology)
  • Diabetic Ketoacidosis (chemically induced, immunology)
  • Female
  • Head and Neck Neoplasms (drug therapy, immunology)
  • Humans
  • Jaw Neoplasms (drug therapy, immunology)
  • Lung Neoplasms (drug therapy, immunology)
  • Male
  • Programmed Cell Death 1 Receptor (immunology)
  • Squamous Cell Carcinoma of Head and Neck

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: